F357-0252 Screening compound: 3-(2-ethoxyphenyl)-1-[4-({4-[3-(2-methylphenyl)-1,2,4-oxadiazol-5-yl]-1H-imidazol-1-yl}methyl)phenyl]urea

F357-0252 Screening compound: 3-(2-ethoxyphenyl)-1-[4-({4-[3-(2-methylphenyl)-1,2,4-oxadiazol-5-yl]-1H-imidazol-1-yl}methyl)phenyl]urea
F357-0252 Screening compound: 3-(2-ethoxyphenyl)-1-[4-({4-[3-(2-methylphenyl)-1,2,4-oxadiazol-5-yl]-1H-imidazol-1-yl}methyl)phenyl]urea alternative view

Chemical Structure Depiction of ChemDiv screening compound F357-0252
3-(2-ethoxyphenyl)-1-[4-({4-[3-(2-methylphenyl)-1,2,4-oxadiazol-5-yl]-1H-imidazol-1-yl}methyl)phenyl]urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F357-0252

Molecular Formula

C28H26N6O3 (C28 H26 N6 O3)

Compound Name

3-(2-ethoxyphenyl)-1-[4-({4-[3-(2-methylphenyl)-1,2,4-oxadiazol-5-yl]-1H-imidazol-1-yl}methyl)phenyl]urea

IUPAC name

3-(2-ethoxyphenyl)-1-[4-({4-[3-(2-methylphenyl)-124-oxadiazol-5-yl]-1H-imidazol-1-yl}methyl)phenyl]urea

SMILES

CCOc(cccc1)c1NC(Nc1ccc(Cn2cnc(-c3nc(-c4c(C)cccc4)no3)c2)cc1)=O

InChI

InChI=1S/C28H26N6O3/c1-3-36-25-11-7-6-10-23(25)31-28(35)30-21-14-12-20(13-15-21)16-34-17-24(29-18-34)27-32-26(33-37-27)22-9-5-4-8-19(22)2/h4-15,17-18H,3,16H2,1-2H3,(H2,30,31,35)

InChI Key

LSSIZAGOCKCZRG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27118633

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

494.55

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

5.702

Distribution Coefficient, logD

5.702

Water Solubility, LogSw

-5.40

Polar Surface Area

82.523

Acid Dissociation Constant (pKa)

12.20

Base Dissociation Constant (pKb)

2.46

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

14.30

F357-0252 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Anticancer Library (62698 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with F357-0252 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F357-0252?
Check Price and Availability of F357-0252, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F357-0252 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F357-0252
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F357-0252
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F357-0252 available by request